TwinBeech Capital’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-51,725
Closed -$25.1M 847
2025
Q3
$25.1M Sell
51,725
-3,119
-6% -$1.45M 0.99% 22
2025
Q2
$22.2M Sell
54,844
-65,060
-54% -$27.2M 0.5% 66
2025
Q1
$59.7M Buy
119,904
+76,283
+175% +$41.3M 1.08% 15
2024
Q4
$22.7M Buy
+43,621
New +$24M 0.39% 87
2024
Q3
Sell
-89,089
Closed -$49.3M 895
2024
Q2
$49.3M Buy
+89,089
New +$51M 0.97% 18
2024
Q1
Sell
-128,800
Closed -$68.4M 846
2023
Q4
$68.4M Buy
128,800
+13,762
+12% +$6.66M 1.1% 9
2023
Q3
$58.2M Buy
115,038
+8,622
+8% +$4.59M 1.12% 8
2023
Q2
$55.5M Buy
+106,416
New +$57.4M 1.1% 11
2023
Q1
Sell
-2,238
Closed -$1.23M 887
2022
Q4
$1.23M Buy
+2,238
New +$1.19M 0.02% 497
2022
Q2
Sell
-798
Closed -$471K 734
2022
Q1
$471K Sell
798
-5,489
-87% -$3.15M 0.02% 394
2021
Q4
$4.2M Buy
+6,287
New +$3.93M 0.24% 121
2021
Q1
Sell
-491
Closed -$229K 670
2020
Q4
$229K Sell
491
-341
-41% -$160K 0.04% 396
2020
Q3
$367K Buy
+832
New +$344K 0.08% 319
2020
Q2
Sell
-11,099
Closed -$3.15M 491
2020
Q1
$3.15M Buy
+11,099
New +$3.5M 1.26% 3

Other funds holding TMO

TwinBeech Capital's TMO Position: Q4 2025 in Review

TwinBeech Capital sold out of Thermo Fisher Scientific (TMO) in Q4 2025, closing a stake of 51,725 shares — an estimated $25.1M sold.

TwinBeech Capital first reported a position in TMO in Q1 2020 and held it in 14 quarters. The position peaked at $68.4M in Q4 2023. 2,699 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

  • TwinBeech Capital reported no remaining Thermo Fisher Scientific position as of Q4 2025 after selling out during the quarter.
  • TwinBeech Capital sold 51,725 Thermo Fisher Scientific shares in Q4 2025, an estimated $25.1M.
  • TwinBeech Capital first reported a position in Thermo Fisher Scientific in Q1 2020 and held it in 14 quarters.
  • TwinBeech Capital's Thermo Fisher Scientific position peaked at $68.4M in Q4 2023.
  • 2,699 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on TwinBeech Capital's 13F filing for Q4 2025, filed 17 Feb 2026.